BREAST CANCER STAGE II

This adverse event was reported 8328 times

These drugs are most commonly taken by patients reporting BREAST CANCER STAGE II:

# Drug Count
0 RANITIDINE 724
1 DICLOFENAC SODIUM 644
2 DICLOFENAC 635
3 METHOTREXATE SODIUM 617
4 RITUXIMAB 615
5 ADALIMUMAB-ADAZ 608
6 LEFLUNOMIDE 608
7 ADALIMUMAB 601
8 SECUKINUMAB 597
9 ALENDRONATE SODIUM 563
See all common drugs associated with BREAST CANCER STAGE II

BREAST CANCER STAGE II is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ASIAN GINSENG 43 0.1019
1 CAFFEINE CITRATE 210 0.0900
2 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 35 0.0532
3 TRIPROLIDINE HYDROCHLORIDE 9 0.0462
4 NEOMYCIN OINTMENT 103 0.0420
5 DICLOFENAC POTASSIUM TABLETS 354 0.0408
6 GOLIMUMAB 466 0.0370
7 DICLOFENAC POTASSIUM 354 0.0320
8 PSEUDOEPHEDRINE HCL 345 0.0315
9 DESOGESTREL AND ETHINYL ESTRADIOL 98 0.0299
See all drugs enriched for association with BREAST CANCER STAGE II